AUNIP

gene
On this page

Also known as MGC2603AIBp

Summary

AUNIP (aurora kinase A and ninein interacting protein, HGNC:28363) is a protein-coding gene on chromosome 1p36.11, encoding Aurora kinase A- and ninein-interacting protein (Q9H7T9). DNA-binding protein that accumulates at DNA double-strand breaks (DSBs) following DNA damage and promotes DNA resection and homologous recombination.

Enables damaged DNA binding activity. Involved in double-strand break repair via homologous recombination; negative regulation of double-strand break repair via nonhomologous end joining; and spindle organization. Located in centrosome; site of DNA damage; and spindle pole.

Source: NCBI Gene 79000 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 62 total
  • MANE Select transcript: NM_024037

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28363
Approved symbolAUNIP
Nameaurora kinase A and ninein interacting protein
Location1p36.11
Locus typegene with protein product
StatusApproved
AliasesMGC2603, AIBp
Ensembl geneENSG00000127423
Ensembl biotypeprotein_coding
OMIM620397
Entrez79000

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000374298, ENST00000481602, ENST00000538789

RefSeq mRNA: 2 — MANE Select: NM_024037 NM_001287490, NM_024037

CCDS: CCDS266, CCDS72731

Canonical transcript exons

ENST00000374298 — 3 exons

ExonStartEnd
ENSE000008725582583741325837554
ENSE000011555122583400625835846
ENSE000014630752585928025859457

Expression profiles

Bgee: expression breadth ubiquitous, 170 present calls, max score 97.62.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.7287 / max 107.7758, expressed in 1220 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
110978.72871220

Top tissues by expression

280 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
oocyteCL:000002397.62gold quality
secondary oocyteCL:000065596.37gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099191.10gold quality
buccal mucosa cellCL:000233686.57gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.00gold quality
spermCL:000001980.91gold quality
right testisUBERON:000453480.60gold quality
testisUBERON:000047379.94gold quality
left testisUBERON:000453379.92gold quality
male germ cellCL:000001579.34silver quality
ventricular zoneUBERON:000305373.62gold quality
ganglionic eminenceUBERON:000402371.58gold quality
bone marrowUBERON:000237171.43gold quality
embryoUBERON:000092271.09gold quality
bone marrow cellCL:000209270.28silver quality
stromal cell of endometriumCL:000225566.75gold quality
prefrontal cortexUBERON:000045166.22gold quality
trabecular bone tissueUBERON:000248365.37silver quality
placentaUBERON:000198764.87gold quality
pancreatic ductal cellCL:000207964.23silver quality
right adrenal gland cortexUBERON:003582764.03gold quality
cortical plateUBERON:000534363.87gold quality
mucosa of transverse colonUBERON:000499163.59gold quality
right adrenal glandUBERON:000123363.36gold quality
left adrenal glandUBERON:000123462.40gold quality
lower esophagus mucosaUBERON:003583462.22gold quality
esophagus mucosaUBERON:000246961.57gold quality
primary visual cortexUBERON:000243661.56gold quality
left adrenal gland cortexUBERON:003582561.45gold quality
monocyteCL:000057661.12gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.61

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

56 targeting AUNIP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-6759-5P99.9966.54785
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-6793-5P99.9765.95758
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-449699.8868.892236
HSA-MIR-807399.8665.211118
HSA-MIR-383-3P99.8565.841359
HSA-MIR-442099.8270.081624
HSA-MIR-181B-2-3P99.8170.061646
HSA-MIR-181B-3P99.8170.061646
HSA-MIR-3934-3P99.7665.511351
HSA-MIR-7856-5P99.7569.992901
HSA-MIR-472999.6972.184233
HSA-MIR-320299.6667.702737
HSA-MIR-317599.6566.302031
HSA-MIR-368599.6268.831621
HSA-MIR-1260A99.6166.671098
HSA-MIR-1260B99.6166.671098
HSA-MIR-5004-3P99.5468.271371

Literature-anchored findings (GeneRIF, showing 2)

  • AIBp may not only be required for the dynamic movement of Aurora-A at the centrosomes and spindle apparatus during the cell cycle, but may also be important during brain tumorigenesis. (PMID:20596670)
  • AUNIP could serve as a candidate diagnostic and prognostic biomarker for OSCC and suppression of AUNIP may be a potential approach to preventing and treating OSCC. (PMID:31409573)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusAunipENSMUSG00000078521
rattus_norvegicusAunipENSRNOG00000022030

Protein

Protein identifiers

Aurora kinase A- and ninein-interacting proteinQ9H7T9 (reviewed: Q9H7T9)

All UniProt accessions (1): Q9H7T9

UniProt curated annotations — full annotation on UniProt →

Function. DNA-binding protein that accumulates at DNA double-strand breaks (DSBs) following DNA damage and promotes DNA resection and homologous recombination. Serves as a sensor of DNA damage: binds DNA with a strong preference for DNA substrates that mimic structures generated at stalled replication forks, and anchors RBBP8/CtIP to DSB sites to promote DNA end resection and ensuing homologous recombination repair. Inhibits non-homologous end joining (NHEJ). Required for the dynamic movement of AURKA at the centrosomes and spindle apparatus during the cell cycle.

Subunit / interactions. Interacts (via C-terminus) with AURKA (via C-terminus). Interacts (via N-terminus) with NIN; this interaction blocks NIN phosphorylation by both AURKA and GSK3B. Identified in a complex with NIN and AURKA. Interacts with RBBP8/CtIP.

Subcellular location. Nucleus. Chromosome. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Spindle pole.

Tissue specificity. Expressed in heart, skeletal muscles, placenta and testis.

Induction. Overexpressed in brain tumors.

Similarity. Belongs to the AUNIP family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9H7T9-11yes
Q9H7T9-22

RefSeq proteins (2): NP_001274419, NP_076942* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR029286AUNIPFamily

Pfam: PF15334

UniProt features (9 total): region of interest 3, modified residue 2, chain 1, compositionally biased region 1, splice variant 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H7T9-F151.650.02

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 267, 292

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 116 (showing top): GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR, ELVIDGE_HYPOXIA_DN, GOBP_NEGATIVE_REGULATION_OF_DNA_REPAIR, GOBP_REGULATION_OF_DNA_REPAIR, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOCC_CENTROSOME, GOBP_REGULATION_OF_RESPONSE_TO_STRESS, GOBP_DNA_DAMAGE_RESPONSE, WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP, GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS, FISCHER_DREAM_TARGETS, GOBP_RECOMBINATIONAL_REPAIR, GOCC_SPINDLE, GOBP_CELL_CYCLE_PROCESS, GOBP_DNA_METABOLIC_PROCESS

GO Biological Process (5): double-strand break repair via homologous recombination (GO:0000724), spindle organization (GO:0007051), negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033), DNA repair (GO:0006281), DNA damage response (GO:0006974)

GO Molecular Function (3): damaged DNA binding (GO:0003684), DNA binding (GO:0003677), protein binding (GO:0005515)

GO Cellular Component (7): spindle pole (GO:0000922), nucleus (GO:0005634), centrosome (GO:0005813), site of DNA damage (GO:0090734), chromosome (GO:0005694), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
intracellular membraneless organelle2
recombinational repair1
double-strand break repair1
microtubule cytoskeleton organization1
cell cycle process1
double-strand break repair via nonhomologous end joining1
negative regulation of double-strand break repair1
regulation of double-strand break repair via nonhomologous end joining1
DNA metabolic process1
DNA damage response1
cellular response to stress1
DNA binding1
nucleic acid binding1
binding1
spindle1
intracellular membrane-bounded organelle1
centriole1
microtubule organizing center1
chromosome1
intracellular anatomical structure1

Protein interactions and networks

STRING

702 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
AUNIPDTLQ9NZJ0623
AUNIPLRRC74BQ6ZQY2479
AUNIPERCC6LQ2NKX8477
AUNIPA0A087WUM3A0A087WUM3446
AUNIPUHRF1Q96T88441
AUNIPANLNQ9NQW6395
AUNIPAIRIMQ9NX04369
AUNIPC6orf136Q5SQH8349
AUNIPTAX1BP1Q86VP1341
AUNIPECT2Q9H8V3340
AUNIPKDM8Q8N371329
AUNIPZFP69Q49AA0324
AUNIPRPA4Q13156316
AUNIPZNF593O00488311
AUNIPTENT5BQ96A09306

IntAct

40 interactions, top by confidence:

ABTypeScore
AUNIPTRIM68psi-mi:“MI:0915”(physical association)0.560
C14orf119AUNIPpsi-mi:“MI:0915”(physical association)0.560
AUNIPNXF1psi-mi:“MI:0915”(physical association)0.560
PRKAB2AUNIPpsi-mi:“MI:0915”(physical association)0.560
AUNIPC14orf119psi-mi:“MI:0915”(physical association)0.560
AUNIPDR1psi-mi:“MI:0915”(physical association)0.560
AUNIPpsi-mi:“MI:0915”(physical association)0.560
AUNIPFGFR3psi-mi:“MI:0915”(physical association)0.560
AUNIPGSNpsi-mi:“MI:0915”(physical association)0.560
AUNIPHRASpsi-mi:“MI:0915”(physical association)0.560
AUNIPGTF3C3psi-mi:“MI:0915”(physical association)0.560
AUNIPTRIM68psi-mi:“MI:0914”(association)0.560
AURKAWDR62psi-mi:“MI:0914”(association)0.530
GRB2AUNIPpsi-mi:“MI:0915”(physical association)0.490

BioGRID (25): AUNIP (Affinity Capture-MS), AUNIP (Two-hybrid), AUNIP (Two-hybrid), AUNIP (Affinity Capture-MS), TRIM68 (Affinity Capture-MS), AUNIP (Two-hybrid), AUNIP (Reconstituted Complex), AUNIP (Affinity Capture-Western), AUNIP (Reconstituted Complex), AUNIP (Biochemical Activity), PRKAB2 (Two-hybrid), NXF1 (Two-hybrid), C14orf119 (Two-hybrid), AUNIP (Affinity Capture-MS), AUNIP (Affinity Capture-MS)

ESM2 similar proteins: A0JM80, A0JNH1, A0JNH9, A3KMW7, A6NMK8, A6QNQ6, B0BM16, B1H1S4, B1WC58, B2GUZ2, D3Z987, D3ZF42, E7FAP1, F6SNN2, P23497, P70347, Q0P5X5, Q14B71, Q283Q6, Q29RT4, Q2M2Z5, Q3U0P1, Q3ULM6, Q3UXL4, Q3V089, Q571C7, Q5HZI1, Q5R9I1, Q5RD97, Q5W0B1, Q6GNV6, Q6KAQ7, Q6P1D7, Q6PDM4, Q7TSY8, Q7ZZH7, Q80WQ8, Q80YR6, Q86YC2, Q8BUH8

Diamond homologs: A4IFU8, D3ZUC4, E9Q6Z5, Q9H7T9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

62 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance54
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

593 predictions. Top by Δscore:

VariantEffectΔscore
1:25837550:TGTGT:Tacceptor_gain1.0000
1:25859288:T:Adonor_gain1.0000
1:25835842:CTTTC:Cacceptor_gain0.9900
1:25835845:TCCTA:Tacceptor_loss0.9900
1:25835847:CT:Cacceptor_loss0.9900
1:25837407:CCATA:Cdonor_loss0.9900
1:25837408:CATA:Cdonor_loss0.9900
1:25837409:ATACC:Adonor_loss0.9900
1:25837410:TA:Tdonor_loss0.9900
1:25837412:C:Gdonor_loss0.9900
1:25837412:CCTGG:Cdonor_gain0.9900
1:25837551:GTGT:Gacceptor_gain0.9900
1:25837555:C:CCacceptor_gain0.9900
1:25839019:TCA:Tdonor_gain0.9900
1:25846868:T:TAdonor_gain0.9900
1:25859275:CCCA:Cdonor_loss0.9900
1:25859276:CCA:Cdonor_loss0.9900
1:25859277:CA:Cdonor_loss0.9900
1:25859278:AC:Adonor_loss0.9900
1:25859287:TTCC:Tdonor_gain0.9900
1:25835843:TTTC:Tacceptor_gain0.9800
1:25835847:C:CCacceptor_gain0.9800
1:25837551:GTGTC:Gacceptor_gain0.9800
1:25837552:TGT:Tacceptor_gain0.9800
1:25837552:TGTC:Tacceptor_loss0.9800
1:25837552:TGTCT:Tacceptor_gain0.9800
1:25837553:GT:Gacceptor_gain0.9800
1:25837553:GTCT:Gacceptor_gain0.9800
1:25837554:TC:Tacceptor_loss0.9800
1:25837555:C:Aacceptor_loss0.9800

AlphaMissense

2370 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:25859318:A:GW14R0.978
1:25859318:A:TW14R0.978
1:25835029:G:CD346E0.976
1:25835029:G:TD346E0.976
1:25859316:C:AW14C0.973
1:25859316:C:GW14C0.973
1:25835203:G:CF288L0.972
1:25835203:G:TF288L0.972
1:25835205:A:GF288L0.972
1:25835196:C:GD291H0.971
1:25835204:A:GF288S0.969
1:25835031:C:GD346H0.968
1:25835022:C:GG349R0.967
1:25835194:A:CD291E0.965
1:25835194:A:TD291E0.965
1:25835030:T:GD346A0.964
1:25859295:C:AK21N0.959
1:25859295:C:GK21N0.959
1:25835030:T:AD346V0.957
1:25835195:T:GD291A0.954
1:25859314:A:GL15P0.954
1:25835195:T:AD291V0.951
1:25835177:A:TV297D0.940
1:25835030:T:CD346G0.935
1:25835004:G:CH355D0.933
1:25835022:C:AG349C0.930
1:25837429:G:CF68L0.927
1:25837429:G:TF68L0.927
1:25837431:A:GF68L0.927
1:25859299:A:GL20P0.926

dbSNP variants (sampled 300 via entrez): RS1000034638 (1:25838657 C>T), RS1000106488 (1:25854076 T>A), RS1000317190 (1:25859621 C>T), RS1000335090 (1:25851848 C>T), RS1000474336 (1:25833703 G>A,T), RS1000503252 (1:25832922 A>C), RS1000529224 (1:25834098 T>C), RS1000572471 (1:25834127 A>T), RS1000637628 (1:25832672 C>T), RS1000943919 (1:25838497 C>A,G,T), RS1001010989 (1:25838743 A>C,T), RS1001246763 (1:25846399 A>G,T), RS1001794383 (1:25856036 A>G), RS1001868042 (1:25857003 C>A,T), RS1002095286 (1:25857060 G>A)

Disease associations

OMIM: gene MIM:620397 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST90002383_126Hematocrit3.000000e-11
GCST90002384_532Hemoglobin6.000000e-12

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004348hematocrit
EFO:0004509hemoglobin measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

31 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases expression, decreases methylation2
Acetaminophendecreases expression, increases expression2
Valproic Acidaffects expression, decreases expression2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
afuresertibdecreases expression1
lasiocarpineincreases expression1
tris(1,3-dichloro-2-propyl)phosphateaffects expression1
sodium arseniteincreases expression1
perfluorooctanoic aciddecreases expression1
manganese chlorideincreases abundance, increases expression1
benzo(e)pyrenedecreases methylation1
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidinedecreases expression, increases response to substance1
Temozolomideincreases expression1
Sunitinibdecreases expression1
Atrazinedecreases expression1
Benzo(a)pyreneincreases expression1
Calcitrioldecreases expression, affects cotreatment1
Cisplatinincreases expression1
Dichlorodiphenyl Dichloroethyleneincreases expression1
Estradiolincreases expression1
Formaldehydedecreases expression1
Manganeseincreases abundance, increases expression1
Methapyrilenedecreases methylation1
Oxygendecreases expression1
Testosteroneaffects cotreatment, decreases expression1
Tetrachlorodibenzodioxindecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
Cyclosporineincreases expression1
Aflatoxin B1increases expression1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_E1RLHAP1 AUNIP (-) 2Cancer cell lineMale
CVCL_XL83HAP1 AUNIP (-) 1Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.